Brind.

The FDA granted clearance for a nerve ablation system from NeuroOne Medical Technologies, which has a distribution agreement with Zimmer Biomet.

3 reports, 3 independent Updated Aug 20
Gone quiet Reached 3 outlets in its first 24 hours
Reports
3
Developments
2
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

The FDA granted clearance for a nerve ablation system from NeuroOne Medical Technologies, which has a distribution agreement with Zimmer Biomet.

Who's involved

What this event is mainly about
Food and Drug AdministrationZimmer Biomet Holdings

How it developed

Newest first. Tap a step to see who reported it.
  1. FDA cleared NeuroOne Medical Technologies' OneRF system for facial pain treatment.Sub-event
  2. FDA cleared a nerve ablation system from NeuroOne, which has a distribution deal with Zimmer Biomet.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • MedTech DiveNeuroOne gains FDA clearance for trigeminal nerve ablation This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter
  • Medical Device NetworkNeuroOne’s nerve ablation system secures FDA clearance NeuroOne Medical Technologies has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its OneRF trigeminal nerve ablati
  • GlobeNewswireNeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical